9/11 Family Steering Committee

Aviation Accident Attorney Evan-Katin Borland Named Partner at Kreindler & Kreindler LLP

Retrieved on: 
Friday, September 15, 2023

NEW YORK, Sept. 15, 2023 /PRNewswire/ -- Kreindler & Kreindler LLP, a leader in aviation accident litigation, is proud to announce the promotion of attorney Evan Katin-Borland to Partner. Mr. Katin-Borland has practiced aviation law with the firm since 2012 and has distinguished himself representing the families of individuals killed or injured as the result of air travel.

Key Points: 
  • NEW YORK, Sept. 15, 2023 /PRNewswire/ -- Kreindler & Kreindler LLP, a leader in aviation accident litigation, is proud to announce the promotion of attorney Evan Katin-Borland to Partner.
  • Mr. Katin-Borland has practiced aviation law with the firm since 2012 and has distinguished himself representing the families of individuals killed or injured as the result of air travel.
  • His peers have named him a Super Lawyers Rising Star in the field of aviation litigation in four of the last five years.
  • Evan is a member of the Steering Committee for the American Bar Association's National Institute on Aviation Litigation.

BioCardia Announces Clarification and Next Steps on its Autologous CardiAMP Cell Therapy Programs

Retrieved on: 
Wednesday, September 6, 2023

SUNNYVALE, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today announced a clarification and next steps on its autologous CardiAMP cell therapy programs.

Key Points: 
  • SUNNYVALE, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today announced a clarification and next steps on its autologous CardiAMP cell therapy programs.
  • Based on the recent interim results in the CardiAMP autologous cell therapy for the treatment of heart failure (BCDA-01), the Company is exploring development of a new Phase III clinical trial protocol.
  • Using the cell population analysis screening criterion to set patient dosage, rather than using it to exclude patients from the study, could accelerate enrollment.
  • BioCardia expects to focus its resources on accelerating this pivotal program ahead and will be incorporating strategies to enhance enrollment.

Trepp Announces The Winners of Inaugural Scholarship Award

Retrieved on: 
Thursday, May 25, 2023

NEW YORK, May 25, 2023 /PRNewswire-PRWeb/ -- Trepp, a leading provider Trepp, a leading provider of data, insights, and technology solutions to structured finance, commercial real estate, and banking markets, announced today the winner of its 2023 Scholarship Award. Trepp awarded John "Jack" Walsh, a rising senior studying to earn a bachelor's in business administration with a focus in Finance, and Real Estate from the University of Cincinnati's Carl H. Linder College of Business, the $10,000 Trepp Scholarship Award, to go toward tuition assistance.

Key Points: 
  • Trepp has announced Jack Walsh of the University of Cincinnati and Mohammed Wara of New York University – Schack Institute of Real Estate, the winners of the inaugural 2023 Trepp Education Scholarship Award.
  • NEW YORK, May 25, 2023 /PRNewswire-PRWeb/ -- Trepp, a leading provider Trepp, a leading provider of data, insights, and technology solutions to structured finance, commercial real estate, and banking markets, announced today the winner of its 2023 Scholarship Award.
  • Trepp awarded John "Jack" Walsh, a rising senior studying to earn a bachelor's in business administration with a focus in Finance, and Real Estate from the University of Cincinnati's Carl H. Linder College of Business, the $10,000 Trepp Scholarship Award, to go toward tuition assistance.
  • More than 50 applicants applied for the scholarship, leaving an arduous task to the Trepp Education Steering Committee to narrow down to six finalists.

EQS-News: Adler Group S.A.: Adler reaches agreement with bondholder group on amendment of note terms and provision of secured debt financing

Retrieved on: 
Sunday, November 27, 2022

The 2023 convertible notes of Adler Group are not subject to the agreement.

Key Points: 
  • The 2023 convertible notes of Adler Group are not subject to the agreement.
  • Adler Group is appreciative of the efforts of the Steering Committee in enabling this important milestone to be achieved.
  • Adler Group has been advised by PJT Partners as financial and White & Case LLP as legal advisor.
  • Adler Group will shortly launch a consent solicitation process to effect certain amendments to the terms and conditions of the Notes.

Liti Capital Announces that a Steering Committee Has Been Formed to Support Traders Who Are Preparing to Pursue Recovery for Millions in Losses Caused by Binance

Retrieved on: 
Thursday, August 19, 2021

Liti Capital is announcing that a Steering Committee has been formed to support traders in their pursuit of recovery against Binance for losses caused when the worlds biggest cryptocurrency exchange failed.

Key Points: 
  • Liti Capital is announcing that a Steering Committee has been formed to support traders in their pursuit of recovery against Binance for losses caused when the worlds biggest cryptocurrency exchange failed.
  • A number of traders have tried to resolve matters with Binance short of pursuing legal claims, but so far have been unsuccessful.
  • Liti Capitals funding will enable affected individuals to pursue claims, including, if necessary, in arbitration, for compensation against Binance.
  • The Steering Committee counts Ms. Lejniece, Mr. David Kay of Liti Capital and three of the affected traders among its members.

AB Science publishes a Q&A press release, following-up on its June 28, 2021 press release relating to an agreement with historical shareholders

Retrieved on: 
Friday, August 6, 2021

AB Science SA (Euronext - FR0010557264 - AB) publishes a Q&A press release, following-up on its June 28, 2021 press release relating to an agreement with historical shareholders.

Key Points: 
  • AB Science SA (Euronext - FR0010557264 - AB) publishes a Q&A press release, following-up on its June 28, 2021 press release relating to an agreement with historical shareholders.
  • Are these directors representatives of the historical shareholders mentioned in the AB Science press release?
  • 3. Who are the historical shareholders mentioned in the AB Science June 28, 2021 press release?
  • Among them, shareholders holding 5.1% of the share capital of AB Science were already in the concert in place within AB Science.